RxDoctor Payments Data

Douglas Dreher, MD

Family Medicine · Chesterton, INNPI 1285604355

Payments from drug & device makers

$4,506in general payments, 2019–2025

Across 116 payments — averaging $38.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$3K
  • AstraZeneca$299
  • Lilly USA, LLC$262
  • Boehringer Ingelheim$245
  • Novo Nordisk$217
  • Merck$168
  • plus $648 from 17 others

What the payments were for

  • Consulting fees$2,49655%
  • Travel & lodging$762%
  • Food & beverage$1,90442%
  • Education$291%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,506 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$118,380
Medicare patients
193
Services billed
1,152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide83$96,523
OzempicSemaglutide50$64,508
XareltoRivaroxaban42$58,887
EliquisApixaban41$50,165
JardianceEmpagliflozin25$36,959
TrulicityDulaglutide21$27,708
FarxigaDapagliflozin Propanediol15$25,182
Breo ElliptaFluticasone/Vilanterol12$6,782
SymbicortBudesonide/Formoterol Fumarate15$6,230
Spiriva HandihalerTiotropium Bromide11$5,472
Tresiba Flextouch U-100Insulin Degludec15$5,416
Atorvastatin Calcium515$3,544
SynthroidLevothyroxine Sodium35$2,358
Omega-3 Acid Ethyl Esters16$1,910
Metoprolol Succinate152$1,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$262$124,231104 claims
Novo NordiskOzempic$217$64,50850 claims
Johnson & JohnsonXarelto$20$58,88742 claims
PfizerEliquis$27$50,16541 claims
Boehringer IngelheimJardiance$245$36,95925 claims
AstraZenecaFarxiga, Symbicort$299$31,41230 claims
GSKBreo Ellipta$67$6,78212 claims
AbbVieSynthroid$96$2,35835 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Chesterton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →